BIOAESIS BT srl is an innovative women’s company founded in 2016 by a group of molecular biologists and has its headquarters in Italy, in the region adjacent to the capital city of Rome.
Bioaesis operates in the biotechnology sector and its main activity is the development and production of biotechnological reagents for laboratory use in clinical and agri-food analysis and markets kits for non-invasive sampling through saliva swabs for DNA tests.
The company is ISO 9001:2015 certified for the design, development, production and testing of biotechnological reagents and components (BV Bureau Veritas) to attest to the excellence in the quality of its organization and reagent production.
The non-invasive collection kits are distributed under the Genokit ® brand, a trademark registered in Italy by Bioaesis.
The company, thanks to its strong biotechnological know-how and the professionals who work there (biologists, doctors, biotechnologists), researches and develops molecular applications commissioned by other companies for the study of genetic polymorphisms predictive of hereditary pathologies which are clearly increasing throughout the world (e.g. Alzheimer’s, cardiovascular diseases, tumors, etc.).
The company also markets kits for the detection and quantification of GMOs present in foods intended for human and livestock consumption. The analytical methods relating to these kits have been recognized for their quality by the Italian accreditation body ACCREDIA (www.accredia.it) pursuant to UNI EN ISO 17025.
The professionals who work at the company offer specialist consultancy in the biotechnology and bioinformatics sector to other companies, including international ones (KAMUT®), thanks to the continuous updating and specialization achieved.
To summarize the activities carried out by the company are:
– Development of methods for
- Detection and quantification of GMOs (genetically modified organisms) through the development of internal methods subject to Accredia accreditation
- Genetic traceability of plant species
- Development of molecular applications for: the detection of SNPs and other genetic polymorphisms; the molecular identification of bacterial and viral pathogens
– Production of reagents for molecular analyses, used in the human healthcare and agri-food sectors.
